3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Human Immunodeficiency Virus (HIV): new trials by email Literature Review of Human Immunodeficiency Virus (HIV) trials Research Report on Human Immunodeficiency Virus (HIV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo - Human Immunodeficiency Virus (HIV) | Phase 3 | Completed | Merck Sharp & Dohme LLC | 734 | 2015-06-05 | 2024-11-20 |
| Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) Darunavir/Ritonavir (DRV/r), Lopinavir in fixed combination with Ritonavir, Zidovudine - Human Immunodeficiency Virus (HIV) | Phase 3 | Completed | Janssen-Cilag G.m.b.H | 312 | 2011-11-25 | 2017-07-19 |
| Impact of Nutrition Intervention on HIV/AIDS Infected Patients Theragran-M; Ensure Plus, Theragran-M - Human Immunodeficiency Virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) | Phase 3 | Completed | Caribbean Health Research Council | 121 | 2008-04-01 | 2010-07-28 |
Acquired Immunodeficiency Syndrome (3) · Occupational Injuries (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · HIV Infections (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Infections (3) · Lentivirus Infections (3) · RNA Virus Infections (3) · Retroviridae Infections (3) · Sexually Transmitted Diseases (3) · Sexually Transmitted Diseases, Viral (3) · Slow Virus Diseases (3) · Urogenital Diseases (3) · Virus Diseases (3)
Darunavir (1) · Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Lamivudine (1) · Lopinavir (1) · Ritonavir (1) · Tenofovir (1) · Theragran-M (1) · Zidovudine (1) · doravirine (1) · efavirenz (1) · lopinavir-ritonavir drug combination (1)
Caribbean Health Research Council (1) · Janssen-Cilag G.m.b.H (1) · Merck Sharp & Dohme LLC (1)
Germany (1) · Jamaica (1)
PMID 30184165, PMID 31121013, PMID 31121015, PMID 33336698, PMID 38141637, PMID 39748155, PMID 40672760, PMID 41081774, PMID 41280318, PMID 42281892
2014 (1)